ISB 830
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ISB 830, covering 2022-06-28 to 2022-06-28. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic Dermatitis [Phase 2]